These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19657588)

  • 1. Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease.
    De Mena L; Coto E; Sánchez-Ferrero E; Ribacoba R; Guisasola LM; Salvador C; Blázquez M; Alvarez V
    J Neural Transm (Vienna); 2009 Oct; 116(10):1289-93. PubMed ID: 19657588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortalin mutations are not a frequent cause of early-onset Parkinson disease.
    Freimann K; Zschiedrich K; Brüggemann N; Grünewald A; Pawlack H; Hagenah J; Lohmann K; Klein C; Westenberger A
    Neurobiol Aging; 2013 Nov; 34(11):2694.e19-20. PubMed ID: 23831374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
    Burbulla LF; Schelling C; Kato H; Rapaport D; Woitalla D; Schiesling C; Schulte C; Sharma M; Illig T; Bauer P; Jung S; Nordheim A; Schöls L; Riess O; Krüger R
    Hum Mol Genet; 2010 Nov; 19(22):4437-52. PubMed ID: 20817635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.
    Chung SJ; Kim MJ; Ryu HS; Kim J; Kim YJ; Kim K; You S; Kim SY; Lee JH
    Neurobiol Aging; 2017 Jan; 49():215.e9-215.e10. PubMed ID: 28340952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
    Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
    Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31.
    Xie H; Hu Z; Chyna B; Horrigan SK; Westbrook CA
    Leukemia; 2000 Dec; 14(12):2128-34. PubMed ID: 11187902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model.
    Zhu JY; Vereshchagina N; Sreekumar V; Burbulla LF; Costa AC; Daub KJ; Woitalla D; Martins LM; Krüger R; Rasse TM
    PLoS One; 2013; 8(12):e83714. PubMed ID: 24386261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-related gene variants influence pre-mRNA splicing processes.
    Gaweda-Walerych K; Mohagheghi F; Zekanowski C; Buratti E
    Neurobiol Aging; 2016 Nov; 47():127-138. PubMed ID: 27574110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.
    Cook TJ; Hoekstra JG; Eaton DL; Zhang J
    Brain Pathol; 2016 Jan; 26(1):75-81. PubMed ID: 26095919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical Consequences of EVEN-PLUS Syndrome Mutations for the Function of Mortalin.
    Moseng MA; Nix JC; Page RC
    J Phys Chem B; 2019 Apr; 123(16):3383-3396. PubMed ID: 30933555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.
    Sánchez-Ferrero E; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Alvarez V
    Parkinsonism Relat Disord; 2009 Jul; 15(6):468-70. PubMed ID: 18980857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease.
    Wu YR; Wang CK; Chen CM; Hsu Y; Lin SJ; Lin YY; Fung HC; Chang KH; Lee-Chen GJ
    Hum Genet; 2004 Feb; 114(3):236-41. PubMed ID: 14605873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Mortalin Correlated with α-Synuclein as Serum Markers in Parkinson's Disease: A Pilot Study.
    Singh AP; Bajaj T; Gupta D; Singh SB; Chakrawarty A; Goyal V; Dey AB; Dey S
    Neuromolecular Med; 2018 Mar; 20(1):83-89. PubMed ID: 29307058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
    Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.
    Alvarez V; Corao AI; Sánchez-Ferrero E; De Mena L; Alonso-Montes C; Huerta C; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; García-Castro M; Coto E
    Neurosci Lett; 2008 Feb; 432(1):79-82. PubMed ID: 18248889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortalin (HSPA9) facilitates
    Wu PK; Hong SK; Chen W; Becker AE; Gundry RL; Lin CW; Shao H; Gestwicki JE; Park JI
    Sci Signal; 2020 Mar; 13(622):. PubMed ID: 32156782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.
    Wadhwa R; Ryu J; Ahn HM; Saxena N; Chaudhary A; Yun CO; Kaul SC
    J Biol Chem; 2015 Mar; 290(13):8447-56. PubMed ID: 25645922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortalin - a multipotent chaperone regulating cellular processes ranging from viral infection to neurodegeneration.
    Flachbartová Z; Kovacech B
    Acta Virol; 2013; 57(1):3-15. PubMed ID: 23530819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
    Royer-Bertrand B; Castillo-Taucher S; Moreno-Salinas R; Cho TJ; Chae JH; Choi M; Kim OH; Dikoglu E; Campos-Xavier B; Girardi E; Superti-Furga G; Bonafé L; Rivolta C; Unger S; Superti-Furga A
    Sci Rep; 2015 Nov; 5():17154. PubMed ID: 26598328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.